Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BTAHO Pharmaceuticals Ltd. 〉TAH8801 Alzheimer's Disease Transdermal Patch

TAH8801 Alzheimer's Disease Transdermal Patch

TAH8801 Alzheimer's Disease Transdermal Patch

Once daily transdermal patch system used for the treatment of mild to moderate Alzheimer's disease.

Request for Collaboration
Overview
TAH8801 is a once a day transdermal patch system used for the treatment of mild to moderate Alzheimer's disease and various other memory impairments. The patch releases medicine continuously over 24 hours. The medication is absorbed through the skin and may be an option for those who have trouble swallowing pills.

Uniqueness
• Reducing dosing frequency due to longer duration
• Improved bioavailability
• Uniform plasma levels, resulting in reduced side effect
• Possibility of terminating the drug administration by simple removal of the patch
• Improved patient compliance via non-invasive, painless and simple application
Collaboration Options
We are seeking to out-license TAH4411 to a pharmaceutical company with suitable sales and marketing in US and Japan.
People who like this also like
  • State-of-the-art FacilityState-of-the-art Facility
  • Locking Plate SystemLocking Plate System
  • TiMAX Dental ServiceTiMAX Dental Service
  • Newborn genetic screening for hearing impairment using real-time PCR with FRET probesNewborn genetic screening for hearing impairment using real-time PCR with FRET probes
  • Six Genomic Technology PlatformsSix Genomic Technology Platforms
  • Methylation-Specific-PCR (MSP)Methylation-Specific-PCR (MSP)
  • TLC599TLC599
  • CHAP™CHAP™
  • Glycan arrays and glycoprobesGlycan arrays and glycoprobes
  • Decellularization matrixDecellularization matrix